IPO diagnostics
An IPO diagnostic is the first step towards a decision to go public. An IPO diagnostic includes a comprehensive review of a business, with an emphasis on compliance with stock exchange rules and the best international practice. Deloitte has already completed a number of successful IPO readiness assessments.
An IPO diagnostic:
- Is required when directors are certain that the company is able to successfully go public within the next three years
- Enables directors to initially identify the issues related to preparation for IPO and revise the company’s operating strategy accordingly
- Allows for the decision of how to present the company to the best possible advantage, while maximizing business value and controlling the timely fulfillment of cost-effective procedures related to an IPO
- Demonstrates the real benefits of the IPO process, as the review often identifies the issues which, if settled, help to reduce costs and increase the company’s value
- Is a cost-effective and quick way to analyze risks before an IPO to establish priorities and develop a plan of actions to ensure the company’s readiness for the IPO.
We provide a company with a report based on our findings, which includes the results of a comprehensive review of the company’s structure and operations, and includes financial due diligence and an assessment of the company’s investment potential, as well as alternative fund-raising options.
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.